Investor Relations header Spectrum Pharmaceuticals Investor Relations picture
      
Oncology, Generics, Neurology Drugs About Spectrum Pharmaceuticals SPPI Investor Relations SPPI News
shadow area

Insider Transactions

Date Name Title Type Shares Traded Price Range
Aug 13, 2010 tidmarsh george f Officer Buy 5,000 4.03
Jul 15, 2010 tidmarsh george f Officer Acquisition (Non Open Market) 15,000 n/a
Jul 6, 2010 mehta dilip j md phd Director Buy 10,000 3.74
Jul 1, 2010 Lenaz, Md, Luigi Director Statement of Ownership 0 n/a
Jul 1, 2010 mehta dilip j md phd Director Statement of Ownership 0 n/a
Jun 24, 2010 Shrotriya, Rajesh , M.d. Officer Buy 10,000 3.84
Jun 4, 2010 Shrotriya, Rajesh , M.d. Officer Buy 10,000 3.96
Apr 19, 2010 fulmer richard Director Buy 4,000 4.83
Apr 12, 2010 Vida, Julius , PH.d. Director Buy 2,500 4.57
Apr 9, 2010 Shrotriya, Rajesh , M.d. Officer Buy 10,000 4.44
Feb 3, 2010 cybulski mitchell p. Director Buy 20,000 4.52
Jan 8, 2010 Kumaria, Shyam , C.p.a. Officer Acquisition (Non Open Market) 10,000 n/a
Jan 8, 2010 Shrotriya, Rajesh , M.d. Officer Acquisition (Non Open Market) 200,000 n/a
Oct 16, 2009 Shrotriya, Rajesh , M.d. Officer Buy 10,000 4.57 - 4.58
Oct 14, 2009 Maida III,, Anthony E. phd, ma, mba Director Sell 21,750 4.62
Oct 14, 2009 Maida III,, Anthony E. phd, ma, mba Director Option Execute 13,000 2.55
Aug 24, 2009 Vida, Julius , PH.d. Director Buy 1,500 6.10
Jul 17, 2009 cybulski mitchell p. Director Buy 20,000 5.58
May 20, 2009 Maida III,, Anthony E. phd, ma, mba Director Buy 1,000 5.15
May 6, 2009 Kumaria, Shyam , C.p.a. Officer Buy 85,000 2.70
Showing 1-20 of 51 transactions Page: 1 2 3  See Next 20

Stock transaction information provided by EDGAR Online. Spectrum Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

Stock Information
NASDAQ:SPPI
$3.86   + 0.08
Sep 2, 2010
4:00 PM ET
Quotes delayed at least 20 minutes.
Information provided by eSignal.
Shareholder Tools

Search Investor Relations



 All contents © Copyright Spectrum Pharmaceuticals, Inc. 2010. All Rights Reserved.  Terms of Use